Population pharmacodynamic model of the longitudinal FEV₁ response to an inhaled long-acting anti-muscarinic in COPD patients

Author： Wu Kai Looby Michael Pillai Goonaseelan Pinault Gregory Drollman Anton Pascoe Steve

Publisher： Springer Publishing Company

ISSN： 1567-567X

Source： Journal of Pharmacokinetics and Pharmacodynamics, Vol.38, Iss.1, 2011-02, pp. : 105-119

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long-Acting Beta-Agonists and their Association with Inhaled Corticosteroids in COPD

Current Medicinal Chemistry, Vol. 20, Iss. 12, 2013-06 ,pp. : 1477-1495

Bentham Science Publishers

Access to resources Recommend Favorite

Advances in Asthma and COPD Treatment: Combination Therapy with Inhaled Corticosteroids and Long-Acting &bgr;2-Agonists.

Current Pharmaceutical Design, Vol. 12, Iss. 25, 2006-01 ,pp. : 3261-3279

Bentham Science Publishers

Access to resources Recommend Favorite

The pharmacodynamic effects of single inhaled doses of formoterol, tiotropium and their combination in patients with COPD

By Cazzola M. Marco F.D. Santus P. Boveri B. Verga M. Matera M.G. Centanni S.

Pulmonary Pharmacology & Therapeutics, Vol. 17, Iss. 1, 2004-02 ,pp. : 35-39

Elsevier

Access to resources Recommend Favorite

Some Pharmacodynamic Aspects on Long-Acting -Adrenoceptor Agonists

By Waldeck B.

General Pharmacology, Vol. 27, Iss. 4, 1996-06 ,pp. : 575-580

Elsevier

Access to resources Recommend Favorite

Long-Acting -Agonists in the Treatment of Acute Exacerbations of COPD

By Cazzola M.

Clinical Drug Investigation, Vol. 22, Iss. 6, 2002-06 ,pp. : 369-376

Adis International

Access to resources Recommend Favorite